You are here

Clinical and Applied Thrombosis/Hemostasis

Clinical and Applied Thrombosis/Hemostasis


eISSN: 19382723 | ISSN: 10760296 | Current volume: 31 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Impact Factor: 2.3.512
  • Indexed In: Clarivate Analytics: Science Citation Index, PubMed/MEDLINE, PubMed Central
  • Publication is subject to payment of an article processing charge (APC)
  • Submit here

Clinical and Applied Thrombosis/Hemostasis (CATH) is a peer-reviewed open access journal which focuses on the practical clinical and laboratory issues involved in managing bleeding and clotting disorders, especially those related to thrombosis, hemostasis, and vascular disorders. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

This journal flipped to open access on August 1, 2017.

Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/cath.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently 3000 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to erin.obrien@sagepub.com.


Other information

This journal changed its publication mode from subscription to open access in 2018.

Clinical and Applied Thrombosis/Hemostasis (CATH) is an open access, peer reviewed journal which is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders.
 
Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal appeal to any person interested in clinical and applied thrombohemorrhagic disorders.

Editor
Charles A. Carter, PharmD, MBA Campbell University, Buies Creek, NC, USA
Senior Editors
Jawed Fareed, Ph.D Loyola University Chicago, USA
Hua He Beijing Anzhen Hospital, China
Deborah Hoppensteadt, Ph.D Loyola University Chicago, USA
Patrick Iversen, PhD  
Walter Jeske, Ph.D Loyola University Medical Center, Maywood, IL, USA
Bulent Kantarcioglu, MD Loyola University Chicago, Department of Molecular Pharmacology & Neuroscience & Department of Pathology and Laboratory Medicine, Maywood, IL, USA
Qing Ma, PharmD, PhD University at Buffalo, Buffalo, NY, USA
Charles “Kurt” Mahan, PharmD, PhC, FCCP, FASHP University of New Mexico, Albuquerque, NM, USA
Wolfgang Miesbach Universitätsklinikum Frankfurt, Germany
Renu Saxena  
Hideo Wada, M.D. Mie University, Japan
Jeanine M. Walenga, Ph.D Loyola University Medical Center, Maywood, IL, USA
Associate Editor
Yang Bai, PhD Chongqing Medical University, China
Dr. Ki Hong Lee Chonnam National University Hospital Cardiology, Korea
Dr. Prakasha Kempaiah, PhD Senior Scientist, Loyola University Chicago, USA
Paresh Kulkarni, MBBS, MD, PhD Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
George M. Rodgers, III, MD, PhD Huntsman Cancer Institute, University of Utah, United States
Dr. Craig Seaman University of Pittsburgh Medicine, Pennsylvania, United States
Editorial Board Members
Fahad Alshehri, PhD King Fisal Medical City for Southern Regions (KFMCity), Aseer Health Cluster (AHC), Abha, Saudi Arabia & Aseer Central Hospital (ACH), Aseer Health Cluster (AHC), Abha, Saudi Arabia
Raul Altman, M.D. Buenos Aires, Argentina
H. Peter Bacher, M.D., Ph.D Long Grove, IL, USA
Gianni Belcaro, M.D., Ph.D Pelcara, Italy
Samuel Berkman, M.D., FACP Bevery Hills, CA, USA
Genmao Cao, M.D. Shanxi Medical University, Taiyuan, China
Anthony K. Chan McMaster University, Canada
Yang Chen, MD, PhD Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK
Sergio Coccheri Bologna, Italy
Muzaffer Demir, M.D. Trakya University, Turkey
Thao T. Doan, MD AbbVie Inc., North Chicago, IL, USA
Esteban Gandara The Ottowa Hospital, General Campus, Canada
Antonio Girolami, M.D. University of Padua, Italy
Charles J. Glueck, M.D. Cholesterol Center, ABC Building
Sylvia Haas, MD Munich, Germany
Mohammad Jamshidi, DO, FACS Millennia Care Clinic, TX, USA
Nicos Labropoulos Stony Brook University Medical Center, Stony Brook, NY, USA
Valery Leytin, Ph.D St. Michael’s Hospital, Toronto, Canada
Fabio Lievano, MD AbbVie Inc., North Chicago, IL, USA
Charles “Kurt” Mahan, PharmD, PhC, FCCP, FASHP University of New Mexico, Albuquerque, NM, USA
Dimitri P. Mikhailidis, M.D., FRCPATH London, England, UK
Michael Mosesson, M.D. University of Wisconsin, USA
Andrew N. Nicolaides London, UK
William F. Pope Dallas, TX, USA
Eduardo Ramacciotti, MD, PhD Hospital e Maternidade Dr Christóvão da Gama, Sao Paulo, Brazil
Rachel Ryu, PharmD, BCPS Western University of Health Sciences, Pomona, CA, USA
Arthur Sasahara, M.D. Boston, MA, USA
Georg-Friedrich von Tempelhoff, M.D. City Hospital of Ruesselshein, Germany
David H. Van Thiel, M.D.  
Emeritus Editor
Editorial Review Board
Dr. Karthigesu Aimanan, MD Department of Surgery, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
Mehmet Baysal, MD Hematology Department Tekirdag I. Fehmi Cumalioglu City Hospital, Turkey
Ivan Budnik, MD, PhD, DSc Department of Internal Medicine, the University of Iowa, Iowa City, Iowa, USA
Ufuk Demirci, MD Department of Hematology, Celal Bayar University, Manisa, Türkiye
Behzad Foroutan, PharmD, PhD Department of Pharmacology, Iranshahr University of Medical Sciences, Iranshahr, Iran
Dr. Grigoris Gerotziafas INSERM, France
Susan Guy, MSc Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK
Yusuf Hosoglu, MD Cardiology Department, Private Koru Kavaklidere Hospital, Ankara, Türkiye
Giovanni Merlino, MD PhD. Udine University Hospital, Udine, Italy
Farouk Mezali, PhD Department of Hydraulics, University of M'sila, M'sila, Algeria
Megha Nataraj, PhD, MPT MGM College of Physiotherapy, Navi Mumbai, Maharashtra, India
Diana-Leh-Ching Ng, MD, MRCP, MMED, Fellowship of Clinical Hematology Department of Medicine, University Malaysia Sarawak, Malaysia
Despoina Pantazi, MSc, PhD University of Ioannina, Greece
Ahmet Cemal Pazarli, MD Department of Pulmonary Diseases, Tokat Gaziosmanpasa University, Tokat, Türkiye
Adriana Peña-Nieves, MSc, PhD Palliative Care Service, National Cancer Institute (INCan), Mexico City, CDMX, Mexico
Nasrin Samji MD, MPH, FRCPC McMaster University , Canada
Antonio Silva Menezes Junior, MD, PhD, FESC Department of Internal Medicine, Federal University of Goiás (UFG), Goiânia, Goiás, Brazil
Rafael de Athayde Soares, Phd, M.D. Instituto de assistência médica ao servidor público estadual de São Paulo (Iamspe)/ São Paulo - SP
Tamrat Assefa Tadesse, PhD Addis Ababa University, Addis Ababa, Ethiopia
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • EMBASE/Excerpta Medica
  • Inpharma Database
  • Ovid: Allied and Complementary Medicine Database
  • ProQuest
  • PubMed: MEDLINE
  • PubMed: PubMed Central (PMC)
  • Reactions Database
  • SciSearch
  • Science Citation Index Expanded (Web of Science)
  • Web of Science: Social Sciences Citation Index (SSCI)
  • Institutional Backfile Purchase, E-access (Content through 1998)

    EC Rep

    International Associates Auditing & Certification Limited
    The Black Church, St Mary's Place,
    Dublin 7, D07 P4AX Ireland
    Sage's GPSR statement